Ann Philbrick, PharmD, FCCP, BCACP
Professor, Department of Pharmaceutical Care & Health Systems and Director of Community Engagement
Contact
Office Address
7-176 WDH 308 Harvard St SE
Minneapolis, MN 55455
United States
Links:
Titles
Professor, Department of Pharmaceutical Care & Health Systems
Professor, Department of Family Medicine and Community Health
Faculty, Woodwinds Family Medicine Residency Program MTM Pharmacist Bethesda Family Medicine Clinic, St. Paul, MN
Director of Community Engagement
Director of Community Engagement
Education
PGY1 Pharmacy Practice Residency, Emphasis in Ambulatory Care, University of Iowa Hospitals and Clinics, Iowa City, IA
PGY2 Specialized Residency, Ambulatory Care, University of Iowa Hospitals and Clinics, Iowa City, IA
PharmD, University of Nebraska
Chemistry-Health Science, Wayne State College, Wayne, NE
Licensures and Certifications
Pharmacotherapy, Ambulatory Care
Biography
Bio
Dr. Ann Philbrick is a professor at the College of Pharmacy and the Department of Family Medicine and Community Health at the University of Minnesota. She is on the faculty of Woodwinds Hospital Family Medicine Residency Program and maintains her pharmacy practice at Bethesda Family Medicine Clinic. She is a 2006 graduate of the University of Nebraska Medical Center and completed a combined PGY1 and PGY2 Ambulatory Care Residency at the University of Iowa Hospitals and Clinics in 2008.
Expertise
Routine immunizations, asthma, COPD, comprehensive medication management (CMM), medical cannabis, diabetes, hypertension
Awards & Recognition
Inductee, University of Minnesota Academy for Excellence in Clinical Practice (2021)
Professional Associations
American College of Clinical Pharmacy
American Association of Colleges of Pharmacy
Society of Teachers of Family Medicine
Minnesota Pharmacist Association
Research Interests
- Pharmacist's role in a family medicine teaching clinic
- Pharmacist’s role in refugee healthcare
- Education and attitudes about medical cannabis
Teaching
Academic Interests and Focus
Immunization Delivery, Medical Cannabis
Teaching Areas
Common infectious diseases encountered in an outpatient setting, including their corresponding vaccines, medical cannabis
Clinical
Clinics
Bethesda Family Medicine Clinic
Clinical Interests
Family Medicine, Comprehensive Medication Management (CMM), asthma, COPD, diabetes, hypertension, preventative care, refugee health care, social determinants of health (SODH), medical cannabis
Clinical Experience Statement
PRACTICE TIME LINE: I completed a 2 year residency in ambulatory care at the University of Iowa Hospitals and Clinics in 2008. I have been practicing at Bethesda Family Medicine since 2008, but the site has had a clinical pharmacist since 1998. PHARMACY ROLE: The clinical pharmacists serve a variety of roles at Bethesda Clinic including: Comprehensive Medication Reviews (CMR), medication reconciliation, anticoagulation management, patient education (diabetes, asthma/COPD, anticoagulation, smok
Publications
Philbrick AM, Carlin CS, Fallert C. Serial blood pressures versus a single repeat blood pressure in a family medicine clinic. Innov Pharm. 2025;16(1):Article 6.
Skogg A, Zagel A, O’Donnell RM, Philbrick AM, Nelson M, Schlichte A, Klasen K. Implementation of a targeted technologic screening tool to increase pneumococcal vaccine uptake in health-system-related pharmacies: a quality improvement initiative. Innov Pharm. 2024;15.
Funk KA, Gonzalez C, Logeais ME, Philbrick AM, Woodruff JA, Robiner WN. Pharmacist homicides in the United States: a retrospective review of NVDRS data from 2003 to 2020. Am J Health Syst Pharm, 2024. Published online ahead of print.
St Peter WL, Bzowyckyj AS, Anderson-Haag T, Awdishu L, Blackman M, Bland A, Chan E, Chmielewski C, Delgado C, Eyler R, Foster C, Hudson J, Kane-Gill SL, Kliethermes MA, Le T, Madabushi R, Martin B, Miller WG, Neumiller JJ, Philbrick AM, Roberts G, Schandorf V, Webb AJ, Wu D, Nolin TD. Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions. Am J Health Syst Pharm, 2024. Published online ahead of print.
Philbrick AM, Pittenger AL. Practice faculty also need sabbatical leaves. Am J Pharm Educ. 2024;88(10):101274.
So M, Jadoo H, Stong J, Klemenhagen KC, Philbrick AM, Freeman K. Effect of virtual versus in person interpreting on diabetes outcomes in non-English language preference patients: a pilot study. J Prim Care Community Health. 2024;15:1-7.
Harris IM, Philbrick AM, Klemenhagen K. Evaluation of single maintenance and reliever therapy (SMART) prescribing of budesonide‐formoterol for asthma after a clinical pharmacist‐led initiative. J Am Col Clin Pharm. 2024;7:215-23.
Philbrick AM, Carlin CS, Harris IM. Fallert C. Using 15-minute serial blood pressures as an alternative to measuring a single blood pressure. Innov Pharm. 2023;14(4):Article 6.
Jadoo H, Klemenhagen K, Freeman K, Philbrick AM. Comparison of clinical pharmacist visits based on language preference in an urban underserved clinic: a cross-sectional analysis. J Am Coll Clin Pharm. 2023;6:1210-5.
Larson RJ, Philbrick AM, Carlin CS, Harris IM. Evaluating the clinical effect of personal continuous glucose monitoring in a diverse population with type 2 diabetes. J Pharm Technol. 2023;39(5):231-6.
Marrs J, Formea C, Abdalla M, Brual R, Crowe S, Freibert K, Herink M, Hoffman A, Philbrick AM, Prescott G, Shahdoost S, Zhou C. Call to Action: Clinical pharmacist roles and opportunities in health disparities research. J Am Col Clin Pharm. 2023;6:297-304.
Austin RR, Philbrick AM, Roth C, Mays KA. Development and implementation of a COVID-19 vaccine and pandemic planning course: an interprofessional education approach. J Interprof Educ Pract. 2022;Dec;29:100540.
Montag Schafer K, Harris IM, Lounsbery JL, Philbrick AM, Moon JY. Shifts in pharmacists’ responsibilities in family medicine residency programs during COVID-19. Innov Pharm. 2022;13:Article 15.
Philbrick AM, Mahoney MT, Harris IM, Carlin CS, Fallert C. Evaluation of thirty-minute office blood pressure in a diverse urban population. Am J Hyperten. 2021;34:1284-90.
Hill JL, Corelli RL, DeHart R, Haney J, Lebovitz L, Philbrick AM, Ross LJ, Sierra C, Jungnickel P. Trends in PCAT requirements and utilization across colleges and schools of pharmacy. Am J Pharm Ed. 2020;85(3):8179.
Philbrick AM, Danner C, Oyenuga A, Pereira C, Ricco J, Wendling A. Education and attitudes on medical cannabis in family medicine residency programs. Fam Med. 2020;52:730-5.